ABIVAX SA (ABVX) Surged by 58% in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 investor letter.
Abivax S.a. (ABVX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 3,178,501 | $439,713,828 | +1% | 8.9% |
| 2. | Point72 Asset Management Steve Cohen | 2,409,154 | $324,886,463 | -18% | 0.36% |
| 3. | Vestal Point Capital Ryan Wilder | 1,900,000 | $256,224,500 | +90% | 8.71% |
| 4. | Caligan Partners David Johnson | 1,451,924 | $195,799,211 | 16.12% | |
| 5. | Paradigm Biocapital Advisors Senai Asefaw | 1,417,473 | $191,153,321 | -10% | 4.88% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 548 | $61,020 | 0% | |
| 2. | 191 | $21,268 | 0% | |
| 3. | 161 | $18,510 | 0% |
News See All
ABIVAX Société Anonyme (ABVX): A Bull Case Theory
We came across a bullish thesis on ABIVAX Société Anonyme on Alpha Talon Investment Research’s Substack by AT Investment Research.
ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs
For the past couple of months, speculation has arisen that Eli Lilly, an American multinational pharmaceutical company, is pursuing a potential acquisition of ABIVAX Société Anonyme (NASDAQ:ABVX).
11 Best Performing Stocks in the Last 12 Months
The year 2025 was not just another year but a period marked by sharp shifts in technology, geopolitics, and trade policy, often driving markets in surprising ways, according to Reuters' year-end report...
ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly
According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly has been drawing interest in the French biotechnology business ABIVAX Socié...
How Abivax (ABVX) Turned Heads With Whopping 1700% Surge in 2025
Abivax skyrocketed by 1,742.28 percent in 2025, as investor sentiment was primarily bolstered by a series of upbeat analyst outlooks, strong clinical trial results, and its official inclusion in Nasdaq...
Is ABIVAX Société Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025?
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the hottest large-cap stocks of 2025.
10 Hottest Large-Cap Stocks of 2025
On December 22, Scott Wren, chief global equity strategist at Wells Fargo Investment Institute, joined CNBC's 'Squawk on the Street' to express optimism regarding accelerating earnings alongside moderating...
Guggenheim Bullish on Abivax (ABVX) Ahead of Key Obefazimod Data Readout
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best emerging technology stocks to invest in.
Hedge Fund Resource Center